Skip to main content
Top
Published in: Journal of Genetic Counseling 5/2013

01-10-2013 | Original Research

Two Decades of Huntington Disease Testing: Patient’s Demographics and Reproductive Choices

Authors: Rebekah C. Krukenberg, Daniel L. Koller, David D. Weaver, Jennifer N. Dickerson, Kimberly A. Quaid

Published in: Journal of Genetic Counseling | Issue 5/2013

Login to get access

Abstract

Predictive testing for Huntington disease (HD) has been available in the United States (US) since 1987, and the Indiana University Predictive Testing Program has been providing this testing since 1990. To date there has been no published description of those who present for such testing in the US. Here we describe demographics of 141 individuals and reproductive decision making of a subset of 16 of those individuals who underwent predictive HD testing between 1990 and 2010 at one site in the US. This study is a retrospective chart review of the “Personal History Questionnaire” participants completed prior to testing. As seen in other studies, most participants were female (64.5 %), in their mid-30s (mean = 34), and had at least one child prior to testing (54 %). Multiple demographic datum points are described, and the reproductive decision making of these at-risk individuals was analyzed using Fisher’s Exact Tests. Of those women who had children before learning of their risk to inherit HD, those who attended church more frequently, had three or more children total, or whose mother was affected with HD were more likely to be comfortable with their choice to have children. We conclude that these demographic factors influence the reproductive decision-making of individuals at risk for HD. Psychologists, clinical geneticists, and genetic counselors may be able to use this information to help counsel at-risk patients regarding current or past reproductive decision making.
Literature
go back to reference Alonso, M. E., Ochoa, A., Sosa, A. L., Rodriguez, Y., Chavez, M., Boll, C., et al. (2009). Presymptomatic diagnosis in Huntington’s disease: the Mexican experience. Genetic Testing and Molecular Biomarkers, 13, 717–720.PubMedCrossRef Alonso, M. E., Ochoa, A., Sosa, A. L., Rodriguez, Y., Chavez, M., Boll, C., et al. (2009). Presymptomatic diagnosis in Huntington’s disease: the Mexican experience. Genetic Testing and Molecular Biomarkers, 13, 717–720.PubMedCrossRef
go back to reference Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Philippe, K., Demyttenaere, K., Dom, R., et al. (2007). The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. European Journal of Human Genetics, 15, 453–462.PubMedCrossRef Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Philippe, K., Demyttenaere, K., Dom, R., et al. (2007). The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. European Journal of Human Genetics, 15, 453–462.PubMedCrossRef
go back to reference Dufrasne, S., Roy, M., Galvez, M., & Rosenblatt, D. S. (2011). Experience over fifteen years with a protocol for predictive testing for Huntington disease. Molecular Genetics and Metabolism, 102, 494–504.PubMedCrossRef Dufrasne, S., Roy, M., Galvez, M., & Rosenblatt, D. S. (2011). Experience over fifteen years with a protocol for predictive testing for Huntington disease. Molecular Genetics and Metabolism, 102, 494–504.PubMedCrossRef
go back to reference Evers-Kiebooms, G., Nys, K., Harper, P., Zoeteweij, M., Dürr, A., Jacopini, G., et al. (2002). Predictive DNA-testing for Huntington’s disease and reproductive decision making: a European collaborative study. European Journal of Human Genetics, 10, 167–176.PubMedCrossRef Evers-Kiebooms, G., Nys, K., Harper, P., Zoeteweij, M., Dürr, A., Jacopini, G., et al. (2002). Predictive DNA-testing for Huntington’s disease and reproductive decision making: a European collaborative study. European Journal of Human Genetics, 10, 167–176.PubMedCrossRef
go back to reference Foroud, T., Gray, J., Ivashina, J., & Conneally, P. M. (1999). Differences in duration of Huntington’s disease based on age at onset. Journal of Neurology, Neurosurgery, and Psychiatry, 66, 52–56.PubMedCrossRef Foroud, T., Gray, J., Ivashina, J., & Conneally, P. M. (1999). Differences in duration of Huntington’s disease based on age at onset. Journal of Neurology, Neurosurgery, and Psychiatry, 66, 52–56.PubMedCrossRef
go back to reference Forrest Keenan, K., Miedzybrodzka, Z., van Teijlingen, E., McKee, L., & Simpson, S. A. (2007). Young people’s experiences of growing up in a family affected by Huntington’s disease. Clinical Genetics, 71, 120–129.PubMedCrossRef Forrest Keenan, K., Miedzybrodzka, Z., van Teijlingen, E., McKee, L., & Simpson, S. A. (2007). Young people’s experiences of growing up in a family affected by Huntington’s disease. Clinical Genetics, 71, 120–129.PubMedCrossRef
go back to reference Genetic Information Nondiscrimination Act of 2008. (2008). § 42 U.S.C. §1635 Genetic Information Nondiscrimination Act of 2008. (2008). § 42 U.S.C. §1635
go back to reference Harper, P. S., Lim, C., & Craufurd, D. (2000). Ten years of presymptomatic testing for Huntington’s disease: the experience of the UK Huntington’s disease prediction consortium. Journal of Medical Genetics, 37, 567–571.PubMedCrossRef Harper, P. S., Lim, C., & Craufurd, D. (2000). Ten years of presymptomatic testing for Huntington’s disease: the experience of the UK Huntington’s disease prediction consortium. Journal of Medical Genetics, 37, 567–571.PubMedCrossRef
go back to reference Huntington, G. (1872). On chorea. In Yudofsky, S.C. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 109–112. (Reprinted from The medical and surgical reporter: A weekly journal, 26, 317–321). Huntington, G. (1872). On chorea. In Yudofsky, S.C. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 109–112. (Reprinted from The medical and surgical reporter: A weekly journal, 26, 317–321).
go back to reference Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983.CrossRef Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983.CrossRef
go back to reference Klitzman, R., Thorne, D., Williamson, J., Chung, W., & Marder, K. (2007). Decision-making about reproductive choices among individuals at-risk for Huntington’s disease. Journal of Genetic Counseling, 16, 347–362.PubMedCrossRef Klitzman, R., Thorne, D., Williamson, J., Chung, W., & Marder, K. (2007). Decision-making about reproductive choices among individuals at-risk for Huntington’s disease. Journal of Genetic Counseling, 16, 347–362.PubMedCrossRef
go back to reference Koenig, H. G. (2009). Research on religion, spirituality, and mental health: a review. Canadian Journal of Psychiatry, 54, 283–291. Koenig, H. G. (2009). Research on religion, spirituality, and mental health: a review. Canadian Journal of Psychiatry, 54, 283–291.
go back to reference Laccone, F., Engel, U., Hollinski-Feder, E., Weigell-Weber, M., Marczinek, K., Nolte, D., et al. (1999). DNA analysis of Huntington’s disease: five years of experience in Germany, Austria, and Switzerland. Neurology, 53, 801–806.PubMedCrossRef Laccone, F., Engel, U., Hollinski-Feder, E., Weigell-Weber, M., Marczinek, K., Nolte, D., et al. (1999). DNA analysis of Huntington’s disease: five years of experience in Germany, Austria, and Switzerland. Neurology, 53, 801–806.PubMedCrossRef
go back to reference Panas, M., Karadima, G., Vassos, E., Kalfakis, N., Kladi, A., Christodoulou, K., et al. (2011). Huntington’s disease in Greece: the experience of 14 years. Clinical Genetics, 80, 586–590.PubMedCrossRef Panas, M., Karadima, G., Vassos, E., Kalfakis, N., Kladi, A., Christodoulou, K., et al. (2011). Huntington’s disease in Greece: the experience of 14 years. Clinical Genetics, 80, 586–590.PubMedCrossRef
go back to reference Puchalski, C. (2001). The role of spirituality in health care. Baylor University Medical Center Proceedings, 14, 352–357.PubMed Puchalski, C. (2001). The role of spirituality in health care. Baylor University Medical Center Proceedings, 14, 352–357.PubMed
go back to reference Quaid, K. A., Swenson, M. M., Sims, S. L., Harrison, J. M., Moskowitz, C., Stepanov, N., et al. (2010). What were you thinking?: individuals at risk for Huntington disease talk about having children. Journal of Genetic Counseling, 19, 606–617.PubMedCrossRef Quaid, K. A., Swenson, M. M., Sims, S. L., Harrison, J. M., Moskowitz, C., Stepanov, N., et al. (2010). What were you thinking?: individuals at risk for Huntington disease talk about having children. Journal of Genetic Counseling, 19, 606–617.PubMedCrossRef
go back to reference Richards, F. H., & Rea, G. (2005). Reproductive decision making before and after predictive testing for Huntington’s disease: an Australian perspective. Clinical Genetics, 67, 404–411.PubMedCrossRef Richards, F. H., & Rea, G. (2005). Reproductive decision making before and after predictive testing for Huntington’s disease: an Australian perspective. Clinical Genetics, 67, 404–411.PubMedCrossRef
go back to reference Roos, R. A. C., Hermans, J., Vegter-van der Vlis, M., van Ommen, G. J. B., & Bruyn, G. W. (1993). Duration of illness in Huntington’s disease is not related to age at onset. Journal of Neurology, Neurosurgery, and Psychiatry, 56, 98–100.PubMedCrossRef Roos, R. A. C., Hermans, J., Vegter-van der Vlis, M., van Ommen, G. J. B., & Bruyn, G. W. (1993). Duration of illness in Huntington’s disease is not related to age at onset. Journal of Neurology, Neurosurgery, and Psychiatry, 56, 98–100.PubMedCrossRef
go back to reference Rubinsztein, D. C., Leggo, J., Coles, R., Almqvist, E., Biancalana, V., Cassiman, J. J., et al. (1996). Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal individuals with 36–39 repeats. American Journal of Medical Genetics, 59, 16–22. Rubinsztein, D. C., Leggo, J., Coles, R., Almqvist, E., Biancalana, V., Cassiman, J. J., et al. (1996). Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal individuals with 36–39 repeats. American Journal of Medical Genetics, 59, 16–22.
go back to reference Simpson, S. A., Besson, J., Alexander, D., Allan, K., & Johnston, A. W. (1992). One hundred requests for predictive testing for Huntington’s disease. Clinical Genetics, 41, 326–330.PubMedCrossRef Simpson, S. A., Besson, J., Alexander, D., Allan, K., & Johnston, A. W. (1992). One hundred requests for predictive testing for Huntington’s disease. Clinical Genetics, 41, 326–330.PubMedCrossRef
go back to reference Sturrock, A., & Leavitt, B. R. (2010). The clinical and genetic features of Huntington disease. Journal of Geriatric Psychiatry and Neurology, 23, 243–259.PubMedCrossRef Sturrock, A., & Leavitt, B. R. (2010). The clinical and genetic features of Huntington disease. Journal of Geriatric Psychiatry and Neurology, 23, 243–259.PubMedCrossRef
go back to reference Taylor, S. (2005). Gender differences in attitudes among those at risk for Huntington’s disease. Genetic Testing and Molecular Biomarkers, 9, 152–157. Taylor, S. (2005). Gender differences in attitudes among those at risk for Huntington’s disease. Genetic Testing and Molecular Biomarkers, 9, 152–157.
go back to reference Trembath, M. K., Tassicker, R. J., Collins, V. R., Mansie, S., Sheffield, L. J., & Delatycki, M. B. (2006). Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. Genetics in Medicine, 8, 673–680.PubMedCrossRef Trembath, M. K., Tassicker, R. J., Collins, V. R., Mansie, S., Sheffield, L. J., & Delatycki, M. B. (2006). Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. Genetics in Medicine, 8, 673–680.PubMedCrossRef
go back to reference United States Huntington’s Disease Genetic Testing Group. (2003). Genetic testing for Huntington’s disease: Its relevance and implications (revised). United States of America: Huntington’s Disease Society of America. United States Huntington’s Disease Genetic Testing Group. (2003). Genetic testing for Huntington’s disease: Its relevance and implications (revised). United States of America: Huntington’s Disease Society of America.
go back to reference Vamos, M., Hambridge, J., Edwards, M., & Conaghan, J. (2007). The impact of Huntington’s disease on family life. Psychosomatics, 48, 400–404.PubMedCrossRef Vamos, M., Hambridge, J., Edwards, M., & Conaghan, J. (2007). The impact of Huntington’s disease on family life. Psychosomatics, 48, 400–404.PubMedCrossRef
go back to reference Van der Meer, L., Timman, R., Trijsburg, W., Duisterhof, M., Erdman, R., Van Elderen, T., et al. (2006). Attachment in families with Huntington’s disease a paradigm in clinical genetics. Patient Education and Counseling, 63, 246–254.PubMedCrossRef Van der Meer, L., Timman, R., Trijsburg, W., Duisterhof, M., Erdman, R., Van Elderen, T., et al. (2006). Attachment in families with Huntington’s disease a paradigm in clinical genetics. Patient Education and Counseling, 63, 246–254.PubMedCrossRef
go back to reference van der Steenstraten, I. M., Tibben, A., Roos, R. A. C., van de Kamp, J. J. P., & Niermeijer, M. F. (1994). Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. American Journal of Human Genetics, 55, 618–625.PubMed van der Steenstraten, I. M., Tibben, A., Roos, R. A. C., van de Kamp, J. J. P., & Niermeijer, M. F. (1994). Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. American Journal of Human Genetics, 55, 618–625.PubMed
go back to reference Venuto, C. S., McGarry, M., Ma, Q., & Kieburtz, K. (2012). Pharmacologic approaches to the treatment of Huntington’s disease. Movement Disorders, 27, 31–41.PubMedCrossRef Venuto, C. S., McGarry, M., Ma, Q., & Kieburtz, K. (2012). Pharmacologic approaches to the treatment of Huntington’s disease. Movement Disorders, 27, 31–41.PubMedCrossRef
go back to reference Williams, J. K., Erwin, C., Juhl, A., Mills, J., Brossman, B., & Paulsen, J. S. (2010). Personal factors associated with reported benefits of Huntington disease family history or genetic testing. Genetic Testing and Molecular Biomarkers, 14, 629–636.PubMedCrossRef Williams, J. K., Erwin, C., Juhl, A., Mills, J., Brossman, B., & Paulsen, J. S. (2010). Personal factors associated with reported benefits of Huntington disease family history or genetic testing. Genetic Testing and Molecular Biomarkers, 14, 629–636.PubMedCrossRef
Metadata
Title
Two Decades of Huntington Disease Testing: Patient’s Demographics and Reproductive Choices
Authors
Rebekah C. Krukenberg
Daniel L. Koller
David D. Weaver
Jennifer N. Dickerson
Kimberly A. Quaid
Publication date
01-10-2013
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 5/2013
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-013-9596-0

Other articles of this Issue 5/2013

Journal of Genetic Counseling 5/2013 Go to the issue